The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satya Vani Nannapaneni
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Satya Vani Nannapaneni, a member of the promoter group of Natco Pharma, sold 45,000 equity shares (face value Rs. 2 each) in the open market on 9 March 2026. This represents about 0.02% of the company's total share capital of 17.91 crore shares. Her holding reduced from 3,79,851 shares (0.21%) to 3,34,851 shares (0.19%). The disclosure was filed under SEBI SAST Regulations 2011 and Form C of the Insider Trading Regulations 2015.
The sale is a minor, routine offloading by an individual promoter group member and is too small (0.02%) to materially affect shareholding pattern or signal any negative intent. Retail investors are unlikely to see any meaningful price impact from this transaction.